Searle Pharma  |  Consumer  |  IBL Health Care

Searle Pharmaceuticals

TSCL is one of the fastest growing pharmaceutical companies in Pakistan. IMS recorded TSCL's 46% growth in quarter and 36% on annual basis in Q4 2009. Moreover, Searle is currently ranked 9th in terms of value.

Comprehensive Range

Our comprehensive line of products encircles life itself - addressing important health needs from infancy to the golden years, in line with our corporate slogan: Research in the Service of Mankind.

The Searle Company Ltd. portfolio includes three major divisions: Pharma, Consumer Health and IBL Health Care. Pharmaceuticals range across therapeutics areas such as Cardiovascular, Respiratory Care, Gastroenterology, Pain Management, CNS, Orhtocare, Neuro-Psychiatry, Probiotics and Nutritional Care.

Category Leadership

The company commands category leadership positions in the following markets:

ExpectorantHydryllin
AntiemeticGravinate
Non NarcoticTramal
Muscle RelaxantNuberol
DiureticSpiromide
AntimotilityLomotil
AntibacterialNegram
ORSPeditral

Sustainable Growth

TSCL is a continuously growing, focusing its activities intensely on new product launches. In 2009/10, Searle launched twenty two brands which clearly depicts the management's ambitions to be the top healthcare company operating in Pakistan.

Moreover, TSCL has strong alliances with its many international partners including Grunenthal of Germany, 3M of England, Sanofi and Forest Laboratories UK Limited (formerly Pharmax).

TSCL has shown tremendous growth within the last two years and has been rated as one of the fastest growing pharma companies in Pakistan.

IMS Facts (Source IMS Q4, 2009)

  • Ranked number 1st in new products sales
  • Ranked number 4th in leading manufacturer in units
  • Ranked number 5th in prescription
  • Ranked 9th in overall value

    Click here view our prescription products.

    Top

    Consumer Products

    TSCL's Consumer Products Division was established in 1990 as a small department, which initially marketed only one product Canderel. Later in 1995 Peditral was added to CPD portfolio and up till 1998 the department only focused on these two brands both of which were locally manufactured.

    In 1998 some imported products were also added to CPD portfolio and the scope of operations extended to local as well as imported brands. However, as a strategic move these imported products have been transferred to IBL Operations (Pvt) Limited (a sister concern of TSCL) since July 2006.

    This has established CPD as the marketing arm for Searle supplementing the sales & distribution strength of the company.

    Top


  •